Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study (FEROS)

This study has been completed.
Ministry of Health, France
Information provided by (Responsible Party):
Rennes University Hospital Identifier:
First received: March 1, 2012
Last updated: May 26, 2015
Last verified: May 2015
The purpose of this study is to describe bone status on patients with genetic hemochromatosis, at diagnostic time and his evolution under treatment.

Genetic Hemochromatosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Bone Status on Patients With Genetic Hemochromatosis : a 3 Years Descriptive and Evolutionary Study.

Resource links provided by NLM:

Further study details as provided by Rennes University Hospital:

Primary Outcome Measures:
  • Bone mineral density [ Time Frame: Change from baseline in bone mineral density at three years ]
    Vertebral and hips Dual energy X-ray Absorptiometry (DXA)

Secondary Outcome Measures:
  • Predictive value of iron overload on Bone Mineral Density [ Time Frame: 1 day ]
  • Number of vertebral fractures [ Time Frame: 3 years ]
  • Number of peripheral fractures [ Time Frame: 3 years ]
  • Number and location of joint lesions detected by the examination (pain and swelling) [ Time Frame: 3 years ]
  • Determination of genetic polymorphism of BMP 2 and 4 [ Time Frame: Baseline ]

Biospecimen Retention:   Samples With DNA
  • serum
  • urine
  • DNA

Enrollment: 100
Study Start Date: July 2008
Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Detailed Description:
Bone diseases have been recognized recently as complications of genetic hemochromatosis. Further studies are needed to describe the role of iron in bone injuries. The purpose of this study is to describe bone status on patients with genetical hemochromatosis, at diagnostic time and his evolution under treatment.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with genetic hemochromatosis diagnosed in western France hospitals

Inclusion Criteria:

  • Patients between 18 and 80 years
  • C282 homozygosity

Exclusion Criteria:

  • corticosteroids during the last 3 months
  • following treatments during the last 6 months : anabolic steroids, growth hormone, hormone therapy for menopause, tibolone, raloxifene.
  • following treatments during inclusion or in the last 6 month : teriparatide, parathormone, fluor, strontium ranelate, biphosphonate.
  • cancer or evolutionary hemopathy (including monoclonal gammopathy)
  • pregnancy at inclusion time
  • treated osteoporosis
  • patient in wich follow up seems hard
  • inclusion in another study incompatible with this one
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01556360

Angers University Hospital
Angers, France, 49933
Brest University Hospital
Brest, France, 29609
Nantes University Hospital
Nantes, France, 44093
Orleans Regional Hospital
Orleans, France, 45100
Poitiers University Hospital
Poitiers, France, 86021
Rennes University Hospital
Rennes, France, 35033
Sponsors and Collaborators
Rennes University Hospital
Ministry of Health, France
Principal Investigator: Guggenbuhl Pascal, MD Rennes University Hospital
  More Information

Responsible Party: Rennes University Hospital Identifier: NCT01556360     History of Changes
Other Study ID Numbers: 2008-A000386-47
Study First Received: March 1, 2012
Last Updated: May 26, 2015

Keywords provided by Rennes University Hospital:
genetic hemochromatosis
Iron overload
C282 homozygosity

Additional relevant MeSH terms:
Metal Metabolism, Inborn Errors
Metabolism, Inborn Errors
Genetic Diseases, Inborn
Iron Overload
Iron Metabolism Disorders
Metabolic Diseases processed this record on May 24, 2017